CommonHealth bets on boom in environmental health programs

Share this article:

CommonHealth has launched Earthborn, an environmental health communications agency.

The WPP network said Earthborn will offer advertising, education and event marketing around the environment and human health to its existing client base of pharmaceutical firms as well as food products manufacturers. Earthborn, supported by experts in communications, environmental medicine and public health, will produce campaigns aimed at multiple internal and external audiences, from local community initiatives to national awareness campaigns.

“Healthcare and Earth-care go hand in hand,” said CommonHealth president and CEO Matt Giegerich, “and we are all stakeholders. With the planet's health at risk, we believe businesses that add environmentalism to their fundamental principles will be rewarded with genuine competitive advantages – inspired employees, loyal customers and greater market share.”

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...